×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| DR.REDDYS LABORATORIES LTD. | 85,314.00 | 14,042.00 | 83,812.00 | 16.94 | 96,115 | 17.9 |
| Mankind Pharma Limited | 24663.9 | 4163.8 | 23965.7 | 10.33 | 96068 | 47.1 |
| APOLLO HOSPITALS ENTERPRISE LT | 55,907.00 | 3,794.00 | 55,269.00 | 25.89 | 90779 | 69.3 |
Dr. Reddy's Laboratories Ltd.,, with Security Code 500124, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,630.6 | 4,880.3 | 3,897.6 | 4,554.0 | 5,437.3 | 4,838.7 | 4,103.0 | 5,104.8 | 5,841.2 | 6,696.3 |
| Expenses | 3,051.1 | 3,077.5 | 3,222.5 | 3,492.9 | 3,209.6 | 3,209.6 | 3,446.7 | 3,726.2 | 3,888.2 | 3,974.7 |
| Operating Profit | 579.5 | 1,802.8 | 675.1 | 1,061.1 | 2,227.7 | 1,629.1 | 656.3 | 1,378.6 | 1,953.0 | 2,721.6 |
| OPM % | 15.96% | 36.94% | 17.32% | 23.3% | 40.97% | 33.67% | 16% | 27.01% | 33.43% | 40.64% |
| Other Income | 403.4 | 118.0 | 51.4 | 114.8 | 233.6 | 223.1 | 227.6 | 212.7 | 217.8 | 207.6 |
| Interest | 9.8 | 1.7 | 2.8 | 2.6 | 4.5 | 5.8 | 5.6 | 5.9 | 7.1 | 28.4 |
| Depreciation | 221.5 | 226.2 | 238.8 | 236.7 | 237.2 | 245.8 | 246.4 | 246.2 | 249.8 | 260.0 |
| Profit before tax | 751.6 | 1,692.9 | 484.9 | 936.6 | 2,219.6 | 1,600.6 | 631.9 | 1,339.2 | 1,913.9 | 2,640.8 |
| Tax % | 33.5% | 34.1% | 33.1% | 28.2% | 26.1% | 25.5% | 24.8% | 22.7% | 26% | 28.7% |
| Net Profit | 499.5 | 1,116.3 | 324.6 | 672.4 | 1,639.4 | 1,192.6 | 475.2 | 1,034.8 | 1,417.2 | 1,882.1 |
| EPS in Rs | 6.01 | 13.42 | 3.9 | 8.08 | 19.69 | 14.31 | 5.7 | 12.41 | 16.99 | 22.56 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,331.8 | 6,789.8 | 6,315.2 | 6,757.9 | 6,902.6 | 7,236.8 | 7,113.8 | 7,696.1 | 8,038.2 | 8,381.2 |
| Expenses | 4,432.9 | 4,851.3 | 4,781.3 | 4,695.8 | 4,894.3 | 5,213.7 | 5,282.6 | 5,566.2 | 5,961.7 | 6,108.2 |
| Operating Profit | 1,898.9 | 1,938.5 | 1,533.9 | 2,062.1 | 2,008.3 | 2,023.1 | 1,831.2 | 2,129.9 | 2,076.5 | 2,273.0 |
| OPM % | 30% | 28.6% | 24.3% | 30.5% | 29.1% | 28% | 25.7% | 27.7% | 25.8% | 27.1% |
| Other Income | 40.8 | 58.7 | 138.5 | 174.0 | 315.0 | 216.2 | 197.5 | 187.2 | 307.5 | 150.2 |
| Interest | 30.9 | 41.8 | 35.4 | 37.1 | 35.3 | 39.4 | 59.3 | 59.8 | 75.7 | 81.7 |
| Depreciation | 309.2 | 323.7 | 315.5 | 353.3 | 375.5 | 373.5 | 367.7 | 380.6 | 397.0 | 471.4 |
| Profit before tax | 1,599.6 | 1,631.7 | 1,321.5 | 1,845.7 | 1,912.5 | 1,826.4 | 1,601.7 | 1,876.7 | 1,911.3 | 1,870.1 |
| Tax % | 31.2% | 24.1% | 27.9% | 24.1% | 22.7% | 24.5% | 18.4% | 26.1% | 30.1% | 25.1% |
| Net Profit | 1,114.2 | 1,243.9 | 960.1 | 1,405.0 | 1,482.2 | 1,380.9 | 1,309.8 | 1,392.4 | 1,341.9 | 1,404.2 |
| EPS in Rs | 13 | 14 | 11 | 16 | 17 | 16 | 15 | 16 | 15 | 16 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 13% |
| 3 Years: | 13% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 27% |
| 3 Years: | 32% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| 1 Year: | -8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 24% |
| 3 Years: | 41% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| 1 Year: | -8% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|